Belgium’s university-industry collaboration model could accelerate EU's advanced therapeutics

EURACTIV - Despite its significant potential, Europe trails North America and the Asian Pacific in Advanced Therapy Medicinal Product (ATMP) development, clinical trials, and investment. Belgium however, boasts one of the highest densities of advanced therapy companies globally. Read more

The Belgian ecosystem lies in its seamless integration of university-industry collaboration, bolstered by robust support from government and regulatory authorities.